Table 2b. Treatment.
Treatment |
HNF4A n=8 |
GCK n=146 |
HNF1A n=43 |
Lecture |
Diet SU GLP-1 RA Insulin |
Diet |
SU Meglitinide, GLP-1 RA, SGLT-2 Insulin |
In our cases |
D: 4 SU: 2 Intensive ins: 2 |
D: 135 SU: 3 OAD (M): 3 Insulin: 2 Intensive ins: 3 |
D: 13 OAD (S): 11 OAD (M): 4 ins: 7 Basal ins+OAD: 2 |
OAD: oral anti-diabetic, M: metformin, D: diet, SU: sulphonylureas, GLP-1 RA: glucagon-like peptide 1 receptor agonist, SGLT-2: sodium-glucose transport protein 2 inhibitors, ins: insuline